Tin tức & Cập nhật
Xem bài viết Dược
Xem

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D
Early albuminuria reduction with finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is responsible for a huge proportion of the treatment effect against CKD progression and facilitates a modest amount of the effect against cardiovascular outcomes, reports a study.
Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D
17 Dec 2023
Baricitinib, ivermectin, favipiravir rank high among COVID-19 oral antivirals
Baricitinib, ivermectin, and favipiravir stood out in terms of efficacy in a network meta-analysis evaluating various novel oral antivirals for the treatment of COVID-19.
Baricitinib, ivermectin, favipiravir rank high among COVID-19 oral antivirals
15 Dec 2023
MAGNITUDE updates in Asian cohort boost NIRA-AAP benefit in BRCA+ mCRPC
In the second interim analysis of the Asian cohort from the phase III MAGNITUDE study, a combination regimen comprising niraparib and abiraterone acetate plus prednisone (NIRA-AAP) improved clinical outcomes in patients with BRCA+ metastatic castration-resistant prostate cancer (mCRPC).






